Analyst consensus rating
InflaRx Analyst Rating: none
IFRX is rated none by 8 analysts with a $7.96 target. As of 2026-08-28.
Direct answer
InflaRx's consensus rating is none.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.96.
Forecast evidence checked August 28, 2026.
Get free InflaRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.27
- Average price target
- $7.96
- High price target
- $14.15
- Low price target
- $3.03
- Low target gap
- +33.6%
- Target upside
- +250.6%
- High target gap
- +523.4%
- Target range width
- 489.8%
- Consensus rating
- none
- Analysts
- 8
- Evidence date
- August 28, 2026
- Valid through
- September 4, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for InflaRx?
InflaRx has a verified none consensus. The same dataset has an average price target of $7.96.
How far are InflaRx's low and high targets from the recorded price?
The low target implies +33.6%, while the high target implies +523.4%.
How many analysts are included in InflaRx's consensus?
The verified consensus includes 8 analysts.
How is InflaRx's target upside or downside calculated?
The average target of $7.96 is divided by the recorded price of $2.27, then one is subtracted to produce +250.6%. This does not guarantee a future return.
When was InflaRx's analyst forecast verified?
The data was verified on 2026-08-28. The dataset is valid through 2026-09-04.